Abstract
With the growing prevalence of diabetes and the associated public health burden, it is crucial to identify modifiable factors that could improve patients' glycemic control. In this work we seek to examine associations between medication usage, concurrent comorbidities, and glycemic control, utilizing data from continuous glucose monitors (CGMs). CGMs provide high-frequency interstitial glucose measurements, but reducing data to simple statistical summaries is common in clinical studies, resulting in substantial information loss. Recent advancements in the Fr & eacute;chet regression framework allow to utilize more information by treating the full distributional representation of CGM data as the response, while sparsity regularization enables variable selection. However, the methodology does not scale to large datasets. Crucially, rigorous inference is not possible because the asymptotic behavior of the underlying estimates is unknown, while the application of resampling-based inference methods is computationally infeasible. We develop a new algorithm for sparse distributional regression by deriving a new explicit characterization of the gradient and Hessian of the underlying objective function, while also utilizing rotations on the sphere to perform feasible updates. The updated method is up to 10,000+ fold faster than the original approach, opening the door for applying sparse distributional regression to large-scale datasets and enabling previously unattainable resampling-based inference. We combine our algorithm with stability selection to perform variable selection inference on CGM data from patients with type 2 diabetes and obstructive sleep apnea. We find a significant association between sulfonylurea medication and glucose variability without evidence of association with glucose mean. We also find that overnight oxygen desaturation variability has a stronger association with glucose regulation than overall oxygen desaturation levels.